Direct-to-Consumer Laboratory Testing Market Size And Share Report, 2032

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Direct-to-Consumer Laboratory Testing Market Size Analysis

Global Direct-to-Consumer Laboratory Testing Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Medical Genetic Laboratory Testing
  1. By Value
3. Routine Clinical Laboratory Testing
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Genetic Testing
  1. By Value
3. COVID-19
  1. By Value
4. Cancer
  1. By Value
5. Diabetes Testing
  1. By Value
6. Disease Risk Assessment Testing
  1. By Value
7. Sexually Transmitted Disease Testing
  1. By Value
8. Routine Testing
  1. By Value
9. Complete Blood Count
  1. By Value
10. CNS-related/Neurological Disease
  1. By Value
11. Thyroid Stimulating Hormone Testing
  1. By Value
12. Others
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Medical Genetic Laboratory Testing
  1. By Value
3. Routine Clinical Laboratory Testing
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Genetic Testing
  1. By Value
3. COVID-19
  1. By Value
4. Cancer
  1. By Value
5. Diabetes Testing
  1. By Value
6. Disease Risk Assessment Testing
  1. By Value
7. Sexually Transmitted Disease Testing
  1. By Value
8. Routine Testing
  1. By Value
9. Complete Blood Count
  1. By Value
10. CNS-related/Neurological Disease
  1. By Value
11. Thyroid Stimulating Hormone Testing
  1. By Value
12. Others
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Medical Genetic Laboratory Testing
    1. By Value
  3. Routine Clinical Laboratory Testing
    1. By Value
2. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Genetic Testing
    1. By Value
  3. COVID-19
    1. By Value
  4. Cancer
    1. By Value
  5. Diabetes Testing
    1. By Value
  6. Disease Risk Assessment Testing
    1. By Value
  7. Sexually Transmitted Disease Testing
    1. By Value
  8. Routine Testing
    1. By Value
  9. Complete Blood Count
    1. By Value
  10. CNS-related/Neurological Disease
    1. By Value
  11. Thyroid Stimulating Hormone Testing
    1. By Value
  12. Others
    1. By Value
3. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Blood
    1. By Value
  3. Urine
    1. By Value
  4. Saliva
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Medical Genetic Laboratory Testing
  1. By Value
3. Routine Clinical Laboratory Testing
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Genetic Testing
  1. By Value
3. COVID-19
  1. By Value
4. Cancer
  1. By Value
5. Diabetes Testing
  1. By Value
6. Disease Risk Assessment Testing
  1. By Value
7. Sexually Transmitted Disease Testing
  1. By Value
8. Routine Testing
  1. By Value
9. Complete Blood Count
  1. By Value
10. CNS-related/Neurological Disease
  1. By Value
11. Thyroid Stimulating Hormone Testing
  1. By Value
12. Others
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Medical Genetic Laboratory Testing
    1. By Value
  3. Routine Clinical Laboratory Testing
    1. By Value
2. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Genetic Testing
    1. By Value
  3. COVID-19
    1. By Value
  4. Cancer
    1. By Value
  5. Diabetes Testing
    1. By Value
  6. Disease Risk Assessment Testing
    1. By Value
  7. Sexually Transmitted Disease Testing
    1. By Value
  8. Routine Testing
    1. By Value
  9. Complete Blood Count
    1. By Value
  10. CNS-related/Neurological Disease
    1. By Value
  11. Thyroid Stimulating Hormone Testing
    1. By Value
  12. Others
    1. By Value
3. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Blood
    1. By Value
  3. Urine
    1. By Value
  4. Saliva
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Medical Genetic Laboratory Testing
  1. By Value
3. Routine Clinical Laboratory Testing
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Genetic Testing
  1. By Value
3. COVID-19
  1. By Value
4. Cancer
  1. By Value
5. Diabetes Testing
  1. By Value
6. Disease Risk Assessment Testing
  1. By Value
7. Sexually Transmitted Disease Testing
  1. By Value
8. Routine Testing
  1. By Value
9. Complete Blood Count
  1. By Value
10. CNS-related/Neurological Disease
  1. By Value
11. Thyroid Stimulating Hormone Testing
  1. By Value
12. Others
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Medical Genetic Laboratory Testing
    1. By Value
  3. Routine Clinical Laboratory Testing
    1. By Value
2. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Genetic Testing
    1. By Value
  3. COVID-19
    1. By Value
  4. Cancer
    1. By Value
  5. Diabetes Testing
    1. By Value
  6. Disease Risk Assessment Testing
    1. By Value
  7. Sexually Transmitted Disease Testing
    1. By Value
  8. Routine Testing
    1. By Value
  9. Complete Blood Count
    1. By Value
  10. CNS-related/Neurological Disease
    1. By Value
  11. Thyroid Stimulating Hormone Testing
    1. By Value
  12. Others
    1. By Value
3. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Blood
    1. By Value
  3. Urine
    1. By Value
  4. Saliva
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Medical Genetic Laboratory Testing
  1. By Value
3. Routine Clinical Laboratory Testing
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Genetic Testing
  1. By Value
3. COVID-19
  1. By Value
4. Cancer
  1. By Value
5. Diabetes Testing
  1. By Value
6. Disease Risk Assessment Testing
  1. By Value
7. Sexually Transmitted Disease Testing
  1. By Value
8. Routine Testing
  1. By Value
9. Complete Blood Count
  1. By Value
10. CNS-related/Neurological Disease
  1. By Value
11. Thyroid Stimulating Hormone Testing
  1. By Value
12. Others
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Medical Genetic Laboratory Testing
    1. By Value
  3. Routine Clinical Laboratory Testing
    1. By Value
2. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Genetic Testing
    1. By Value
  3. COVID-19
    1. By Value
  4. Cancer
    1. By Value
  5. Diabetes Testing
    1. By Value
  6. Disease Risk Assessment Testing
    1. By Value
  7. Sexually Transmitted Disease Testing
    1. By Value
  8. Routine Testing
    1. By Value
  9. Complete Blood Count
    1. By Value
  10. CNS-related/Neurological Disease
    1. By Value
  11. Thyroid Stimulating Hormone Testing
    1. By Value
  12. Others
    1. By Value
3. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Blood
    1. By Value
  3. Urine
    1. By Value
  4. Saliva
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Medical Genetic Laboratory Testing
  1. By Value
3. Routine Clinical Laboratory Testing
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Genetic Testing
  1. By Value
3. COVID-19
  1. By Value
4. Cancer
  1. By Value
5. Diabetes Testing
  1. By Value
6. Disease Risk Assessment Testing
  1. By Value
7. Sexually Transmitted Disease Testing
  1. By Value
8. Routine Testing
  1. By Value
9. Complete Blood Count
  1. By Value
10. CNS-related/Neurological Disease
  1. By Value
11. Thyroid Stimulating Hormone Testing
  1. By Value
12. Others
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Medical Genetic Laboratory Testing
    1. By Value
  3. Routine Clinical Laboratory Testing
    1. By Value
2. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Genetic Testing
    1. By Value
  3. COVID-19
    1. By Value
  4. Cancer
    1. By Value
  5. Diabetes Testing
    1. By Value
  6. Disease Risk Assessment Testing
    1. By Value
  7. Sexually Transmitted Disease Testing
    1. By Value
  8. Routine Testing
    1. By Value
  9. Complete Blood Count
    1. By Value
  10. CNS-related/Neurological Disease
    1. By Value
  11. Thyroid Stimulating Hormone Testing
    1. By Value
  12. Others
    1. By Value
3. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Blood
    1. By Value
  3. Urine
    1. By Value
  4. Saliva
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Direct-to-Consumer Laboratory Testing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

23andMe, Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Ambry Genetics Corp.
Any Lab Test Now, Inc.
Direct Laboratory Services LLC
EverlyWell, Inc.
Genesis Healthcare Co.
MyMedLab, Inc.
OME Care
Pixel by LabCorp
Quest Diagnostics Incorporated
Shuwen Biotech Co. Ltd.
Thryve Inc.
Ulta Lab Tests, LLC
Vitagene, Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment